本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

68.81
-0.1500-0.22%
盘后68.810.00000.00%16:31 EDT
成交量:52.40万
成交额:3,639.11万
市值:29.05亿
市盈率:-29.75
高:70.84
开:68.72
低:68.70
收:68.96
52周最高:76.81
52周最低:38.51
股本:4,221.41万
流通股本:3,035.16万
量比:1.21
换手率:1.73%
股息:- -
股息率:- -
每股收益(TTM):-2.3129
每股收益(LYR):-3.0729
净资产收益率:-31.46%
总资产收益率:-14.06%
市净率:8.73
市盈率(LYR):-22.39

数据加载中...

2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/17

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]